Electra
South San Francisco, US · Delaware corporation · 46 employees on LinkedIn · 7 known investors
Find your way into Electra
Sign up to see every warm intro you have to Electra
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Electra team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Electra Therapeutics develops antibody therapeutics targeting Signal Regulatory Protein (SIRP) for immunological diseases and cancer treatment. The company explores and validates novel drug targets with a focus on breakthrough therapies addressing underlying disease pathology.
Founders & leadership

Board
Investors · 7
How we know: HBM Healthcare Investments's portfolio page · Not right? Tell us
How we know: HBM Partners's portfolio page · Not right? Tell us
How we know: OrbiMed's portfolio page · a partner's Signal profile · the VCSheet dataset · Not right? Tell us
How we know: Westlake Village BioPartners's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$134.2M disclosed across 1 round · 2025
▶$134.2MraisedOct 2025 · 19 investors · BiotechnologyRule 506(b)
- Beth Seidenberg, M.D.Director
- Thomas Geninatti, Ph.D.Director
- Matthew FustDirector
- Carl Gordon, Ph.D.Director
- Nancy Stagliano, Ph.D.Director
- Quehuong (Kathy) Dong, Pharm.D.Executive Officer, Director
- Offering amount
- $184.1M
- Amount sold
- $134.2M
- First sale
- Oct 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Electra Therapeutics went on to found or lead other companies.
Related companies · 2
Companies working in the same space as Electra.
In the news
Frequently asked questions
- What does Electra do?
- Electra Therapeutics develops antibody therapeutics targeting Signal Regulatory Protein (SIRP) for immunological diseases and cancer treatment. The company explores and validates novel drug targets with a focus on breakthrough therapies addressing underlying disease pathology.
- Who founded Electra?
- Electra was founded by Adam Rosenthal.
- Who are Electra's investors?
- Electra's investors include HBM Healthcare Investments, HBM Partners, OrbiMed, RA Capital, Westlake Village BioPartners, Kleiner Perkins, NVIDIA.
- How much funding has Electra raised?
- Electra has disclosed $134.2M raised across 1 round.
- Where is Electra headquartered?
- Electra is headquartered in South San Francisco, US.





